GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis
出版年份 2021 全文链接
标题
GSK-3 Inhibition Modulates Metalloproteases in a Model of Lung Inflammation and Fibrosis
作者
关键词
-
出版物
Frontiers in Molecular Biosciences
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-06-21
DOI
10.3389/fmolb.2021.633054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer
- (2019) Linda O’Flaherty et al. PLoS One
- Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma
- (2019) Kensaku Abe et al. CANCER SCIENCE
- Macrophages: Their role, activation and polarization in pulmonary diseases
- (2018) Shweta Arora et al. IMMUNOBIOLOGY
- Phosphorylation of the Cytoskeletal Protein CAP1 Regulates Non-Small Cell Lung Cancer Survival and Proliferation by GSK3β
- (2018) Shuanshuan Xie et al. Journal of Cancer
- Modulation of Wnt signaling is essential for the differentiation of ciliated epithelial cells in human airways
- (2017) Andreas Schmid et al. FEBS LETTERS
- Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion
- (2017) Kamdeo K. Pramanik et al. CELLULAR ONCOLOGY
- The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis
- (2017) Franco Conforti et al. Oncotarget
- GSK-3β and MMP-9 Cooperate in the Control of Dendritic Spine Morphology
- (2016) Ilona Kondratiuk et al. MOLECULAR NEUROBIOLOGY
- Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis
- (2015) Vanessa J. Craig et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The role of TIMPs in regulation of extracellular matrix proteolysis
- (2015) Valerie Arpino et al. MATRIX BIOLOGY
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of Glycogen Synthase Kinase-3β Attenuates Organ Injury and Dysfunction Associated With Liver Ischemia-Reperfusion and Thermal Injury in the Rat
- (2015) Joao Rocha et al. SHOCK
- Glycogen Synthase Kinase 3 Sustains Invasion of Glioblastoma via the Focal Adhesion Kinase, Rac1, and c-Jun N-Terminal Kinase-Mediated Pathway
- (2014) Y. Chikano et al. MOLECULAR CANCER THERAPEUTICS
- Dickkopf-3 (Dkk3) induces apoptosis in cisplatin-resistant lung adenocarcinoma cells via the Wnt/β-catenin pathway
- (2014) ZHENG WANG et al. ONCOLOGY REPORTS
- Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells
- (2014) Eun Kim et al. RESPIRATORY RESEARCH
- Glycogen synthase kinase-3 (GSK-3) regulates TGF-β1-induced differentiation of pulmonary fibroblasts
- (2013) Hoeke A Baarsma et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expression of the Atypical Chemokine Receptor D6 in Human Alveolar Macrophages in COPD
- (2013) Erica Bazzan et al. CHEST
- Ex vivomicro-computed tomography analysis of bleomycin-induced lung fibrosis for preclinical drug evaluation
- (2013) Chris J. Scotton et al. EUROPEAN RESPIRATORY JOURNAL
- Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
- (2013) Ayako Kitano et al. PLoS One
- SB216763, a selective small molecule inhibitor of glycogen synthase kinase-3, improves bleomycin-induced pulmonary fibrosis via activating autophagy
- (2013) Hong Liu et al. Acta Pharmaceutica Sinica B
- Epigenetic regulation of mmp-9 gene expression
- (2012) Marilyne Labrie et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The myofibroblast matrix: implications for tissue repair and fibrosis
- (2012) Franco Klingberg et al. JOURNAL OF PATHOLOGY
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- 3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a Mouse Model of Pulmonary Inflammation and Fibrosis
- (2009) C. Gurrieri et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- TGF-β1 targets the GSK-3β/β-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts
- (2008) F CARACI et al. PHARMACOLOGICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now